about the author

Lia DeGroot

ldegroot@endpointsnews.com

author articles

In rare move, Colom­bia is­sues com­pul­so­ry li­cense for HIV med­i­cine in ef­fort to ex­pand ac­cess

Last year
Pharma
FDA+

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Last year
China
Pharma

Califf talks bol­ster­ing do­mes­tic drug man­u­fac­tur­ing, for­eign in­spec­tions at House hear­ing

Last year
Pharma
FDA+

Lu­mi­cell nabs FDA ap­proval for drug-de­vice breast can­cer de­tec­tion sys­tem

Last year
Pharma
FDA+

FDA hits Nat­co with warn­ing let­ter over In­dia fa­cil­i­ty, sus­pends prod­uct ship­ments to US

Last year
Pharma
FDA+

GAO ex­am­ines state PBM reg­u­la­tion as Con­gress weighs wider re­forms

Last year
Pharma
FDA+

New FDA tri­al in­no­va­tion cen­ter launch­es with demon­stra­tion to in­crease in­dus­try in­ter­ac­tions

Last year
Pharma
FDA+

EMA probe finds no causal link be­tween semaglu­tide and sui­ci­dal thoughts, self-harm

Last year
Pharma
FDA+

FDA com­mis­sion­er calls on House com­mit­tee to help com­bat drug short­ages

Last year
Pharma
FDA+

En­do sues FDA over its han­dling of gener­ic Adren­a­lin ap­provals

Last year
Pharma
FDA+

No­var­tis, Sanofi and PhRMA push FDA on how to bet­ter han­dle com­plex tri­al de­signs

Last year
Pharma
FDA+

Vir­ginia gov­er­nor ve­toes bill to cre­ate ad­vi­so­ry board to re­duce drug prices

Last year
Pharma
FDA+

Near­ly half of can­cer drugs grant­ed ac­cel­er­at­ed ap­proval didn’t end up show­ing clin­i­cal ben­e­fit — study

Last year
Pharma
FDA+

Loos­en­ing Med­ic­aid re­stric­tions on hep C drugs could im­prove pa­tient ac­cess, study finds

Last year
Pharma
FDA+

Paxlovid didn’t short­en Covid symp­toms in vac­ci­nat­ed adults, full tri­al re­sults con­firm

Last year
Pharma
FDA+

WuXi builds out lob­by­ing bench amid leg­isla­tive ef­fort to black­list com­pa­ny

Last year
China
Pharma

CBER's Marks points to stock­piles of H5N1 vac­cine as of­fi­cials mon­i­tor re­port­ed hu­man case

Last year
Pharma
FDA+

Bernie Sanders im­plores No­vo to cut list prices of Ozem­pic, We­govy

Last year
Pharma
FDA+

FDA’s CDER es­tab­lish­es new cen­ter of ex­cel­lence fo­cused on quan­ti­ta­tive med­i­cine

Last year
Pharma
FDA+

SCO­TUS rais­es ques­tions over le­gal stand­ing in abor­tion pill case

Last year
Pharma
FDA+

ARPA-H calls on AI de­vel­op­ers to help tack­le cy­ber­at­tacks

Last year
AI
FDA+

Lead House spon­sor of WuXi-linked bill to leave Con­gress ear­ly

Last year
People
China

Sen­a­tors push HHS on ‘in­ad­e­quate’ re­sponse to Change Health­care cy­ber­at­tack

Last year
FDA+
Health Tech

Glob­al AIDS pro­gram re­vived in gov­ern­ment spend­ing pack­age as oth­er health rid­ers fall off

Last year
Pharma
FDA+
First page Previous page 123456 Next page Last page
A service from the Financial Times